Intracameral phenylephrine to prevent floppy iris syndrome during cataract surgery in patients on tamsulosin.
OBJECTIVE
To describe the use of intracameral phenylephrine to prevent the floppy iris syndrome seen in patients who are on the drug tamsulosin for benign prostatic hypertrophy, during cataract surgery.


METHODS
Prince Charles Eye Unit, King Edward VII Hospital, Windsor, Berkshire, UK.


METHODS
Seven patients who were on systemic tamsulosin for benign prostatic hypertrophy received intracameral phenylephrine before capsulorexhis during their cataract surgery.


RESULTS
There was a significant reduction in the amount of mobility of the iris, reduction in the expected fluttering, and sustained papillary dilatation. ConclusionIntracameral phenylephrine is a simple and effective tool to prevent the effects of floppy iris syndrome in those patients undergoing cataract surgery who are on systemic tamsulosin.
Gurbaxani
A
A
Department of Ophthalmology, King Edward VII Hospital, Windsor, Berkshire, UK. avigurbaxani@ yahoo.co.in
Packard
R
R
D058668:Adrenergic alpha-1 Receptor Antagonists; D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects*; D000368:Aged; D000369:Aged, 80 and over; D002387:Cataract Extraction / Q000379:methods*; D006801:Humans; D007267:Injections; D007431:Intraoperative Complications / Q000517:prevention & control*; D007498:Iris / Q000187:drug effects; D007499:Iris Diseases / Q000517:prevention & control*; D008297:Male; D010656:Phenylephrine / Q000008:administration & dosage*; D011680:Pupil / Q000187:drug effects; D013449:Sulfonamides / Q000009:adverse effects*; D013566:Sympathomimetics / Q000008:administration & dosage*; D013577:Syndrome; D000077409:Tamsulosin
D058668:Adrenergic alpha-1 Receptor Antagonists; D000317:Adrenergic alpha-Antagonists; D013449:Sulfonamides; D013566:Sympathomimetics; D010656:Phenylephrine; D000077409:Tamsulosin